Clinical Trial Update: Circulating Transforming Growth Factor Beta (TGF-β) in Individuals With Marfan Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial investigating circulating transforming growth factor beta (TGF-β) in individuals with Marfan syndrome was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marfan Syndrome

Snippet

Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago | Conditions: Marfan Syndrome | Phase 3 | Status: WITHDRAWN